IMA Stock Analysis: Buy, Sell, or Hold?
IMA - ImageneBio, Inc. Common Stock
$7.51
0.18 (2.53%)
▲
5d:
+4.02%
30d:
+5.63%
90d:
-14.56%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
30d
Get Alerted When IMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMA is currently trading at $7.51, which is considered extended relative to its 30-day fair value range of $6.41 to $7.24.
Technical Outlook: Technically, IMA is in a strong downtrend. The price is approaching resistance at $7.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+299.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMA is in a strong downtrend. The price is approaching resistance at $7.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+299.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$6.41 -
$7.24
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 299.5% below Wall St target ($30.00)
Fair Price Analysis
30-Day Fair Range
$6.41 -
$7.24
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$6.01
Resistance Level
$7.60
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.26
Wall Street Target
$30.00
(+299.5%)
Last updated: February 01, 2026 10:49 PM ET
Data refreshes hourly during market hours. Next update: 11:49 PM
Data refreshes hourly during market hours. Next update: 11:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |